The recent success of continuous-flow circulatory support devices has led to the growing
acceptance of these devices as a viable therapeutic option for end-stage heart failure …

Durable implantable left ventricular assist devices (LVADs) have been shown to improve
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …

Background The use of left ventricular assist devices is an accepted therapy for patients with
refractory heart failure, but current pulsatile volume-displacement devices have limitations …

This will be a substantial revision of a good selling text for upper division/first graduate
courses in biomedical transport phenomena, offered in many departments of biomedical and …

Progress in the field of prosthetic cardiovascular devices has significantly contributed to the
rapid advancements in cardiac therapy during the last four decades. The concept of …

Background Insertion of an implantable left ventricular assist device (LVAD) complicated by
early right ventricular (RV) failure has a poor prognosis and is largely unpredictable …

BACKGROUND: Continuous-flow left ventricular assist devices (LVAD) are increasingly
being used in patients with end-stage heart failure and have largely replaced older …

BACKGROUND: Pulsatile left ventricular assist devices (LVADs) are effective as bridge-to-
transplant therapy, but they are limited by their large size and lack of durability. Smaller …

Background Left ventricular assist devices (LVADs) are increasingly used in patients with
heart failure. To study the impact of stroke on clinical outcomes after continuous-flow (CF-) …

OBJECTIVE: Thromboembolic events can occur in up to 20% of patients with a left
ventricular assist device. The aggressive use of anticoagulation with newer continuous-flow …